1. Di-tert-butyl Phosphonate Route to the Antiviral Drug Tenofovir
- Author
-
Dorota Ferenc, Jule-Philipp Dietz, B. Frank Gupton, Timothy F. Jamison, and Till Opatz
- Subjects
adefovir ,Tert butyl ,Active ingredient ,Tenofovir ,010405 organic chemistry ,medicine.drug_class ,Organic Chemistry ,oxymethyl phosphonates ,010402 general chemistry ,01 natural sciences ,Combinatorial chemistry ,Phosphonate ,Article ,tenofovir ,0104 chemical sciences ,chemistry.chemical_compound ,antivirals ,chemistry ,phosphites ,medicine ,Adefovir ,Physical and Theoretical Chemistry ,Antiviral drug ,medicine.drug - Abstract
Di-tert-butyl oxymethyl phosphonates were investigated regarding their suitability for preparing the active pharmaceutical ingredient tenofovir (PMPA). First, an efficient and simple access to the crystalline di-tert-butyl(hydroxymethyl)phosphonate was developed. O-Mesylation gave high yields of the active phosphonomethylation reagent. For the synthesis of tenofovir, a two-step sequence was developed using Mg(OtBu)2 as the base for the alkylation of (R)-9-(2-hydroxypropyl)adenine. Subsequent deprotection could be achieved with aqueous acids. (Di-tert-butoxyphosphoryl)methyl methanesulfonate showed to be the most efficient electrophile tested, affording PMPA in 72% yield on a 5 g scale. The developed protocol could also be applied for the preparation of the hepatitis B drug adefovir (64% yield/1 g scale).
- Published
- 2021
- Full Text
- View/download PDF